Answers are grounded in this paper and cite their sources.
The synthesis and structure-activity profile of a new class of potent and highly specific thromboxane A2 synthetase inhibitors is described. The most potent member of this series in vitro is determined to be imidazo[1,5-a]-pyridine-5-hexanoic acid (9).
No takes yet. Share an insight, caveat, or question.
Ford et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: